Identification of multiple cyclin subunits of human P-TEFb
about
Tat-SF1 protein associates with RAP30 and human SPT5 proteinsEvidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitroStructure and function of the human transcription elongation factor DSIFHEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SKIdentification of HEXIM1 as a positive regulator of p53The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expressionSelective inhibition of BET bromodomainsThe La-related protein LARP7 is a component of the 7SK ribonucleoprotein and affects transcription of cellular and viral polymerase II genesTFIID component TAF7 functionally interacts with both TFIIH and P-TEFbThe human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcriptionThe structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylationAnalysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stagesDephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription.Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA.Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasomeCDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNARelief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoterThe C-terminal domain phosphatase and transcription elongation activities of FCP1 are regulated by phosphorylationDomains in the SPT5 protein that modulate its transcriptional regulatory propertiesThe growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcriptionCoordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcriptionBinding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitorTIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcriptionCrystal structure of HIV-1 Tat complexed with human P-TEFbRecruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML proteinRegulation of P-TEFb elongation complex activity by CDK9 acetylationMAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent mannerCrystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcriptionComparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKsA uniform procedure for the purification of CDK7/CycH/MAT1, CDK8/CycC and CDK9/CycT1Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5Small-molecule inhibitors of the Myc oncoproteinCyclin Box Structure of the P-TEFb Subunit Cyclin T1 Derived from a Fusion Complex with EIAV TatComparative Structural and Functional Studies of 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 Inhibitors Suggest the Basis for Isotype SelectivityBUR1 and BUR2 encode a divergent cyclin-dependent kinase-cyclin complex important for transcription in vivo.Physical interaction between pRb and cdk9/cyclinT2 complexActivation of MyoD-dependent transcription by cdk9/cyclin T2
P2860
0a3093ec1a2577a3e71227e853badb2b27375cb31d5ca0b14b60b0670ec6576d7696c5e02e9dc8631fdf2dbbdca094aad10f2c108a92025d7051277a520bc1f7d277371bb81d2b24daaf525fafa4b0d283aed1140b57bf1c5ac5d4da957affc7129a6a62b7cff9a476f9fe4aeea198c784381fb2aaf2496fbf26d34cc27572acc69750abc2a59b0e01a4f563c468edc151f0e7195beaacc7e9b51504bb7619c3c4c1a0e817d9e1eeea6c97ad8503b48de6dc7c1dd79e744a74c5a45439b0b416e56cc0421cb0616bee922d10ad274837fa5decbe7b26a1877f99392d
P248
Q22003803-27996BA5-D887-4F0E-A821-365E7CB0CBD9Q22008559-BCC7244D-6237-4906-A11C-1CEE9FEC4C3FQ22009021-A7EBFD9B-AB90-4D06-9787-82F725573311Q24294998-18FCB01A-6CDD-4F29-AAAB-F4194D1005CBQ24297975-7488A642-C329-4EDB-927D-1F5259CDA0A5Q24298498-1A34E020-C756-44F4-B38D-718356BAE229Q24301009-57C64AA8-CEEA-4138-AE66-68FFB4A7D2ECQ24313106-BFEC2F73-D051-4695-8F11-BD6181CC286BQ24317617-76B90FB4-A1C3-4808-AEED-9D354E810BE6Q24318776-8ED1A72E-D17B-443C-9F29-AAB061DB8683Q24323313-97E0A965-976E-411A-9EE3-102717B7D254Q24527261-1431241B-D950-42F9-AEC2-4CA0085D5986Q24533266-72C7C941-1366-4D9B-80E6-8964832950EDQ24535568-5D7D5BC0-C246-4426-80C8-ECBA74B19B4CQ24537283-4F1F91C1-7D1D-4573-8AC0-B96B197DC1B2Q24548261-61D0893F-3212-4B5B-91C5-BA6E7B0C42DFQ24550765-23F79322-5151-4E7B-8323-9299B4F15F70Q24552532-C3FF4FDB-F6E3-4CBB-BA62-39ED4901152DQ24553772-166A68C9-49BA-4E20-B07B-A4E4887AF08BQ24554258-5C814417-D25F-4E57-A381-7B7F4955B481Q24554329-5598571E-75BE-4DF2-BF59-8FD35AF440A5Q24559797-BF6EC021-77F2-4912-B831-511FA67A74FDQ24563382-BF240A43-B354-4E87-9D9F-6E29CE04210DQ24600874-89F3A943-3721-4967-9315-5DBDE814E5A4Q24634280-7388C503-F1E9-455B-A103-778CC96655D5Q24634569-94655E34-8FD3-4E3A-9F24-A2FB67461BBBQ24675942-EC66EA2C-012C-4300-B815-D540C8BFB1E3Q24675988-E247EFDA-17CE-46E1-A22F-A162AC0F9EA6Q24679741-D1CFC260-7CFA-4AC6-BE2A-9C097BC42625Q24683471-C8AB1B4C-1D36-4000-B021-413655F11139Q24684924-FFD48033-4D94-4A1B-8438-53A90C1FCA81Q24796929-4A1B0BF7-8D05-494F-9C29-E7E84C35E28CQ24801238-35B820DC-5954-498F-B1F4-B413DFCC824DQ24808657-61743078-853D-4744-AA8E-2ECE2A2C3205Q27025648-0F1F47BA-5ACA-44BD-8E36-EAD7C10BA4C6Q27645094-E3062215-561F-4F35-AC15-06F0CB1708ADQ27675539-26D9DC96-55A8-4698-88B7-75C0EB061B3CQ27933584-61900FF1-3E1E-4071-A4A0-F9B8CE0508ECQ28114798-29600ADD-1F61-4836-99FC-77B687295B7FQ28115623-B445258A-E2AB-4D5A-A5C6-DEAA8C75BFFD
P2860
Identification of multiple cyclin subunits of human P-TEFb
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Identification of multiple cyclin subunits of human P-TEFb
@ast
Identification of multiple cyclin subunits of human P-TEFb
@en
Identification of multiple cyclin subunits of human P-TEFb
@en-gb
Identification of multiple cyclin subunits of human P-TEFb
@nl
type
label
Identification of multiple cyclin subunits of human P-TEFb
@ast
Identification of multiple cyclin subunits of human P-TEFb
@en
Identification of multiple cyclin subunits of human P-TEFb
@en-gb
Identification of multiple cyclin subunits of human P-TEFb
@nl
prefLabel
Identification of multiple cyclin subunits of human P-TEFb
@ast
Identification of multiple cyclin subunits of human P-TEFb
@en
Identification of multiple cyclin subunits of human P-TEFb
@en-gb
Identification of multiple cyclin subunits of human P-TEFb
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Identification of multiple cyclin subunits of human P-TEFb
@en
P2093
P2860
P304
P3181
P356
10.1101/GAD.12.5.755
P407
P577
1998-03-01T00:00:00Z